These returns cover a period from January 1, 1988 through July 6, 2020. Get the latest Aurinia Pharmaceuticals Inc AUPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Set an interval! also free.We use cookies to understand how you use our site and to improve your experience. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Aurinia Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $25.80, an 87.5% upside from current levels. See rankings and related performance below.The scores are based on the trading styles of Value, Growth, and Momentum. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Log in to see them here or sign up to get started.Create a list of the investments you want to track.Visit a quote page and your recently viewed tickers will be displayed here.Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aurinia Pharmaceuticals (AUPH) and Fresenius Medical ...[...]There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aurinia Pharmaceuticals (AUPH) and IMV ...[...]Aurinia Pharmaceuticals, Inc.'s (AUPH) CEO Peter Greenleaf on Q2 2020 Results - Earnings Call TranscriptAurinia (AUPH) delivered earnings and revenue surprises of -13.04% and -53.23%, respectively, for the quarter ended June 2020. An increase of 18% from the average daily volume of 1,603,728 shares. Aurinia Pharmaceuticals, Inc. analyst report, Walletinvestor This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. There may be delays, omissions, or inaccuracies Get detailed information on Aurinia Pharmaceuticals stock (NASDAQ: AUPH), including today’s stock quote, real-time price, financial history, charts, and more. Set a candle Delayed quotes by Sungard.NYSE and AMEX data is at least 20 minutes delayed.

Quote & News AUPH stock price predictions 2020, In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Zacks Ranks stocks can, and often do, change throughout the month. AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. Neither Zacks Investment . . Is Aurinia Pharmaceuticals, Inc. price going up? The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.The technique has proven to be very useful for finding positive surprises.

future stock price will be Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. AUPH prediction, AUPH stock future price, AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.

View Aurinia Pharmaceuticals Inc AUPH investment & stock information. If you are looking for stocks with good return, Aurinia Pharmaceuticals, Inc. can be a profitable investment option. See rankings and related performance below.The scores are based on the trading styles of Value, Growth, and Momentum.